MA53141A - Procédés de différenciation de l'hyperplasie prostatique bénigne d'un cancer de la prostate - Google Patents

Procédés de différenciation de l'hyperplasie prostatique bénigne d'un cancer de la prostate

Info

Publication number
MA53141A
MA53141A MA053141A MA53141A MA53141A MA 53141 A MA53141 A MA 53141A MA 053141 A MA053141 A MA 053141A MA 53141 A MA53141 A MA 53141A MA 53141 A MA53141 A MA 53141A
Authority
MA
Morocco
Prior art keywords
differentiating
processes
prostate cancer
prostatic hyperplasia
hyperplasia under
Prior art date
Application number
MA053141A
Other languages
English (en)
Inventor
Michael Andrew Kiebish
Niven Rajin Narain
Rangaprasad Sarangarajan
Poornima Tekumalla
Original Assignee
Berg Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berg Llc filed Critical Berg Llc
Publication of MA53141A publication Critical patent/MA53141A/fr

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57555Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/34Genitourinary disorders
    • G01N2800/342Prostate diseases, e.g. BPH, prostatitis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/56Staging of a disease; Further complications associated with the disease
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
MA053141A 2018-07-12 2019-07-12 Procédés de différenciation de l'hyperplasie prostatique bénigne d'un cancer de la prostate MA53141A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862697292P 2018-07-12 2018-07-12

Publications (1)

Publication Number Publication Date
MA53141A true MA53141A (fr) 2021-05-19

Family

ID=69138842

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053141A MA53141A (fr) 2018-07-12 2019-07-12 Procédés de différenciation de l'hyperplasie prostatique bénigne d'un cancer de la prostate

Country Status (6)

Country Link
US (1) US20200018758A1 (fr)
EP (1) EP3821031A4 (fr)
AU (1) AU2019301756B2 (fr)
CA (1) CA3106191A1 (fr)
MA (1) MA53141A (fr)
WO (1) WO2020014593A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000029948A1 (it) * 2020-12-04 2022-06-04 Nib Biotec S R L Metodo per la diagnosi di tumore alla prostata in pazienti in differente fascia di età
GB202111635D0 (en) * 2021-08-13 2021-09-29 Randox Laboratories Risk prediction model for prostate cancer
CN118497334B (zh) * 2024-06-05 2025-08-01 武汉大学中南医院 抑制flnc基因表达的物质在制备治疗良性前列腺增生的药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482599B1 (en) * 1999-04-30 2002-11-19 Hybritech Incorporated Forms of prostate specific antigen (PSA) specific for benign prostatic hyperplasia (BPH) and methods of using such
UA62739A (en) * 2003-05-14 2003-12-15 Nat Tech Univ Kyiv Polytech A method for applying silicide coatings on the steels surface
WO2013173517A1 (fr) * 2012-05-15 2013-11-21 Mcclelland, Michael Marqueurs biologiques du stroma pour le diagnostic du cancer de la prostate
US10539566B2 (en) * 2014-12-08 2020-01-21 Berg Llc Use of markers including filamin A in the diagnosis and treatment of prostate cancer
WO2018085441A1 (fr) * 2016-11-01 2018-05-11 Berg Llc Protéines de liaison de filamine b et leurs utilisations
US10759850B2 (en) * 2016-11-01 2020-09-01 Berg Llc Filamin A binding proteins and uses thereof

Also Published As

Publication number Publication date
AU2019301756A1 (en) 2021-01-28
WO2020014593A8 (fr) 2020-03-12
CA3106191A1 (fr) 2020-01-16
EP3821031A4 (fr) 2022-07-20
AU2019301756B2 (en) 2026-02-05
EP3821031A1 (fr) 2021-05-19
US20200018758A1 (en) 2020-01-16
WO2020014593A1 (fr) 2020-01-16

Similar Documents

Publication Publication Date Title
EP3433238A4 (fr) Agents à affinité élevée ayant pour cible un antigène membranaire spécifique de la prostate, utilisés pour l'endoradiothérapie du cancer de la prostate
EP3589732A4 (fr) Détection du cancer de la prostate
ZA202006008B (en) Psma-targeted radiopharmaceutical for diagnosing and treating prostate cancer
DK3336197T3 (da) Epigenetiske markører og relaterede fremgangsmåder og midler til detektion og behandling af ovariekræft
MX2022008100A (es) Uso de compuestos de cloroquina y clemizol para el tratamiento de afecciones inflamatorias y cancerosas.
IL276748A (en) Methods for the detection and treatment of prostate cancer
LT3490560T (lt) Būdas prostatos vėžiui gydyti naudojant niraparibą
EP3433383A4 (fr) Procédés d'amplification quantitative
MA53141A (fr) Procédés de différenciation de l'hyperplasie prostatique bénigne d'un cancer de la prostate
EP3565560A4 (fr) Procédés prédictifs et diagnostiques pour le cancer de la prostate
EP3775171A4 (fr) Procédés de traitement d'un cancer résiduel minimal
EP3894561A4 (fr) Procédés de traitement du cancer
IL288408A (en) Methods of treating urinary system cancers
EP3691536A4 (fr) Appareil et procédé de détermination de probabilité spatiale d'un cancer dans la prostate
IL285056A (en) Prostate cancer treatment methods based on molecular subtypes
IL281281A (en) Combination therapy for the treatment of prostate cancer
EP4087585A4 (fr) Compositions et procédés de prévention de la récurrence de cancer
EP3426310A4 (fr) Biopsie de liquide prostatique pour la détection du cancer de la prostate et de l'hyperplasie bénigne de la prostate
EP3830134A4 (fr) Compositions et procédés de détection du cancer de la prostate
EP3425392A4 (fr) Procédé de détection d'un cancer de la prostate résistant à la castration et réactif de détection
EP3864415A4 (fr) Procédés de prise de décisions de traitement du cancer de la prostate
EP3816628A4 (fr) Marqueur de détermination du cancer du pancréas
EP3405583A4 (fr) Compositions et procédés pour le dépistage et l'identification d'un cancer de la prostate cliniquement agressif
EP3470528A4 (fr) Méthode de prédiction de l'effet d'une pharmacothérapie sur le cancer
EP3415637A4 (fr) Procédé d'identification de développement de carcinome basaloïde cellulaire de l' sophage